These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14572800)

  • 1. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
    Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
    Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihistaminic drug olopatadine downmodulates CCL17/TARC production by keratinocytes and Langerhans cells.
    Sugita K; Kobayashi M; Mori T; Kabashima K; Nakamura M; Tokura Y
    J Dermatol; 2009 Dec; 36(12):654-7. PubMed ID: 19958451
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
    Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
    J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
    Katoh N; Hirano S; Kishimoto S; Yasuno H
    Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fexofenadine downmodulates antigen-presenting ability of murine epidermal Langerhans cells.
    Sugita K; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jan; 49(1):88-91. PubMed ID: 17950577
    [No Abstract]   [Full Text] [Related]  

  • 6. Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes.
    Murata K; Sugita K; Kobayashi M; Kabashima K; Tokura Y
    J Dermatol Sci; 2006 May; 42(2):91-9. PubMed ID: 16431082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells.
    Seiffert K; Hosoi J; Torii H; Ozawa H; Ding W; Campton K; Wagner JA; Granstein RD
    J Immunol; 2002 Jun; 168(12):6128-35. PubMed ID: 12055224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice.
    Atarashi K; Kabashima K; Akiyama K; Tokura Y
    Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.
    Kurimoto I; Grammer SF; Shimizu T; Nakamura T; Streilein JW
    Immunology; 1995 Aug; 85(4):621-9. PubMed ID: 7558158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Granstein RD
    J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms in the induction phase of contact sensitivity.
    Knop J; Enk AH
    Int Arch Allergy Immunol; 1995; 107(1-3):231-2. PubMed ID: 7613139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.
    Sugita K; Kabashima K; Atarashi K; Shimauchi T; Kobayashi M; Tokura Y
    Clin Exp Immunol; 2007 Jan; 147(1):176-83. PubMed ID: 17177977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
    Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
    J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roxithromycin down-modulates antigen-presenting and interleukin-1 beta-producing abilities of murine Langerhans cells.
    Ohshima A; Tokura Y; Wakita H; Furukawa F; Takigawa M
    J Dermatol Sci; 1998 Jul; 17(3):214-22. PubMed ID: 9697050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of Langerhans cells to Thy-1+ dendritic epidermal cells in murine epidermis influences the intensity of contact hypersensitivity.
    Bigby M; Kwan T; Sy MS
    J Invest Dermatol; 1987 Nov; 89(5):495-9. PubMed ID: 2889783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL-2H3) cells.
    Matsubara M; Masaki S; Ohmori K; Karasawa A; Hasegawa K
    Biochem Pharmacol; 2004 Apr; 67(7):1315-26. PubMed ID: 15013847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes.
    Gaspari AA; Katz SI
    J Immunol; 1991 Dec; 147(12):4155-61. PubMed ID: 1753091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
    Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
    J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
    Tamura T; Matsubara M; Hasegawa K; Ohmori K; Karasawa A
    Clin Exp Allergy; 2005 Jan; 35(1):97-103. PubMed ID: 15649273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.